Search

Post doc: The Pride Laboratory is seeking a Postdoctoral Fellow to investigate the role of bacteriophages as members of the human microbiome and to assist in the efforts to identify bacteriophages that kill human pathogens.

Post doc positions: Multiple postdoctoral scientist positions (2+ years) are available in the School of Biological Sciences at the Georgia Institute of Technology in Atlanta to work on phage therapy & marine virus ecology.

Scientific Director: Janssen Biopharma Inc. is seeking an experienced and highly motivated Scientific Director to lead the discovery of novel antibacterial therapeutic agents, including phages.

Drafting international guidelines for phage banks — initial brainstorming & organizational meeting We would like to gather a working group that will draft suggested guidelines over the coming months. This brainstorming meeting is open to a

The Phage Bites symposium is back! With student/ECR talks and expert guest panelists Keith Shearwin, Stefanie Barbirz and Michael J. McDonald discussing #phage #adaptive #strategies. Free to attend! 2nd Aug 2022. Online. Register and submit

Jon Iredell (Director of Phage Australia) & Jessica Sacher (Phage Directory) will take part in an interactive ‘Meet the Researcher’ webinar hosted by the WIMR Foundation on phage therapy for AMR infections, and the work they’re doing at Pha

The newly formed Belgian Society for Viruses of Microbes is excited to announce a 1-day inaugural symposium on Sept 23rd, 2022 in Leuven, Belgium! In parallel, the BSVoM team is guest-editing a special issue in Viruses. They call on all Be

News: LyseNTech, a Korean phage company led by Heejoon Myung, was named a leading research institute by the Korean Ministry of Trade, Industry and Energy. LyseNTech aims to develop 'LNT103', a phage-derived endolysin, as an inhaled treatmen

Paper: Evading while invading: induction of CRISPR-Cas by mucin as a mean to escape phages adhered to mucus.

Paper: Bacteriostatic effects of phage F23s1 and its endolysin on Vibrio parahaemolyticus.

Pre-print: The defence island repertoire of the Escherichia coli pan-genome.

Pre-print: Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny.

This week Madhav Madurantakam Royam, a PhD student at the University of Warwick, talks to Dr. Alexander Sulakvelidze, founder and CEO of Intralytix, one of the first modern phage companies to have products on the market. This week Madhav Ma

PHAGE Journal is celebrating the 130th birthday of George Eliava with a focused issue of phage therapy then and now — just released! Phage Therapy: Insights from the Past, the Great Need of the Present, and Glimpses into the Future A snea

Paper: Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome.

Paper: Effect of freeze drying, spray drying and electrospraying on the morphological, thermal, and structural properties of powders containing phage Felix O1 and activity of phage Felix O1 during storage.

Paper: Widespread phages of endosymbionts: Phage WO genomics and the proposed taxonomic classification of Symbioviridae.

Paper: Bacteriophage-mediated perturbation of defined bacterial communities in an in vitro model of the human gut.

Review: Novel antimicrobial agents for combating antibiotic-resistant bacteria.

Postbaccalaureate fellow: The Stibitz lab at the FDA (Silver Spring, MD) is recruiting a postbaccalaureate fellow to characterize and engineer the lytic activity of Lactic acid bacteria bacteriophage endolysins.